Achieving Routine Intervention and Screening for Emotional Health
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- University of Chicago
- Study ID
- NCT06887049
- Status
- Recruiting
Conditions
- Diabetes Distress
- Type 2 Diabetes Mellitus (T2DM)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- ARISE Learning Community Diabetes Distress Screening and Intervention — BEHAVIORALIn-depth training for frontline community health center staff on ARISE algorithm to screen for degree of diabetes distress using T2-DDAS Core. If positive, screen for sources of diabetes distress using T2-DDAS Sources. Discuss results with patient and make any relevant referrals.
- ARISE Enhanced Care brief training — BEHAVIORALBrief training on American Diabetes Association guidelines for screening for diabetes distress using the 7A's model
Study Details
The purpose of this project is to evaluate the effectiveness of diabetes distress screening and intervention on patients with type 2 diabetes mellitus (T2DM).
Key Dates
- Start date
- Mar 10, 2026
- Status verified
- Jun 2026
- Primary completion
- Sep 30, 2027
- Completion
- Sep 30, 2028
Study Design
- Enrollment
- 1,250 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SCREENING
Arms
- Experimental: ARISE Learning Community ArmCommunity Health Centers will be given an in-depth training on the ARISE screening and intervention algorithm
- Other: ARISE Enhanced CareCommunity Health Centers will be given a brief training on the 7A's model of diabetes distress screening and intervention
Primary Outcome Measure
Rate of A1C across time [ Time Frame: 12 months ]
Central Contacts
- Abby Sr. Research Project Manager, MSW773-834-5646
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Chicago | Chicago | Illinois | 60637 |
Find similar trials in Chicago, IL
By research site
Related Studies
- RCT Glargine vs NPH for Treatment of DM in PregnancyPHASE3 · Recruiting · Loyola University · Maywood, Illinois
- Low-Dose Pioglitazone in Patients With NASH (AIM 2)PHASE2 · Recruiting · University of Florida · Gainesville, Florida
- Human Immunodeficiency Virus (HIV) Food InsecuritiesRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- Developing and Testing a Self-Compassion Tool Kit to Improve the Care of Individuals With Type 2 DiabetesRecruiting · University of California, San Diego · San Diego, California